v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

CLINICAL MANIFESTATIONS OF SARS-COV-2 (COVID19)

AUTHORS:

Shaheer Zahid, Dr. Imtiaz Ahmad, Dr.Sehar Altaf, Muhammad Wajeeh Nazar, Muhammad Haider

ABSTRACT:

By the end of December 2019, multiple new cases of pneumonia were reported. All of these cases had a particular characteristic in common; they had been caused by a new virus named by the WHO as Covid-19 and the International Committee on Taxonomy of Viruses called it, SARS-CoV-2. In order to discuss the clinical manifestation and symptoms of the 2019-Covid-19. It is imperative to describe the virus's characteristics and structure; This is an RNA positive-strand virus, a non-segmented belonging to the family of Coronaviridae widely distributed between humans and mammals(1). This virus can be asymptomatic or produce a "common flu" symptoms and death through its complications. Fever, cough, and difficulty in breathing are the most important manifestations to declare a patient as a suspicious case; comorbidities with age, past medical history, time of diagnosis, and treatment received are the most important predictor of the prognosis of the disease. Until 23rd of May, 2020, the world health organization has 5,306,237 confirmed cases and 340,047 deaths (2). Key words: covid-19, susceptibility, clinical manifestation, follow up

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.